Customer session · September 2026

Inside the ELTON pipeline.

A session for existing ELTON customers. We walk through what the pipeline actually is, how AI is used to write testing tools rather than read your product data, what changes in your findings when it is switched on, and how to enable it for your products.

Existing customers only45 min + Q&ANo additional cost
Date · Wednesday, September 16, 2026 Time · 11:00 AM ET Host · Jason Sinchak, CEO
Reserve your seat
Why we are running this

It is available to you, and it is not automatic.

The expanded pipeline is not switched on across the board. We enable it customer by customer, product by product, so we can set expectations about access, scope and what your findings will look like afterwards. This session is where that starts. Attend, ask questions, and tell us which products you want covered first.

No additional cost

It is included in the subscription you already have. Nothing to buy, no change order, no new statement of work. The only thing we need from you is a conversation about which products go first.

Enabled per product

Every device is different in what access it allows and what interfaces it exposes. We turn the pipeline on per product so the coverage is real rather than nominal.

What we will cover

Five things you will leave knowing.

This is a technical explainer, not a product pitch. If your security or regulatory team has questions about how AI is used on your product, this is the session to send them to.

A pipeline, not a prompt

What the pipeline actually is: a toolchain built over thirteen years of medical device testing, not a model asked to go find vulnerabilities.

Where your data goes

The short answer is nowhere. We show the boundary: what stays inside ELTON, and what we send to a model, which is our own engineering work.

The five agentic loops

How continuous development writes new testing tools around the clock, and why that capability compounds instead of resetting every engagement.

What changes in your findings

More issues surface, and they arrive sorted: directly exploitable, conditionally exploitable, or a weakness with no path today.

The human gate

Nothing the pipeline surfaces reaches you unreviewed. We walk through who reviews what, and what that means for the quality of your record.

What it means for FDA

Where the added coverage and traceability show up in a submission, and how to talk about your use of AI with a reviewer.

Who should attend

Bring the people who will get asked about it.

Product security and engineering

The teams who receive the findings and own the fixes. They will want the detail on classification, access, and what shows up in the queue.

Regulatory and quality

The teams who have to describe your testing to a reviewer, and who will get the question about how AI was used on the product.

Cannot make the date? Register anyway. We send the replay and the slides to everyone who signs up.
September 2026

Save your seat.

A customer-only walkthrough of the pipeline, how it is built, and how to switch it on for your products.

Questions

Common questions about Inside the ELTON Pipeline.

Who can attend Inside the ELTON Pipeline?

This session is for existing ELTON customers only. It is included at no additional cost in the subscription you already have, with nothing to buy and no change order. Bring product security and engineering, who receive the findings and own the fixes, and regulatory and quality, who have to describe your testing to a reviewer.

What does the session cover?

The session is a technical explainer, not a product pitch. It covers what the pipeline actually is, a toolchain built over thirteen years of medical device testing rather than a model asked to go find vulnerabilities, plus where your data goes, the five agentic loops, what changes in your findings, the human review gate, and what it means for FDA.

Where does our device data go?

Customer data does not go into a model. The session walks the boundary: what stays inside ELTON, and what is sent to a model, which is ELTON's own engineering work. AI is used to write the testing tools, not to read your product information, and the session shows exactly where that line sits.

Is the expanded pipeline switched on automatically for our products?

It is enabled customer by customer and product by product, not across the board. Every device differs in what access it allows and which interfaces it exposes, so it is turned on per product to keep the coverage real rather than nominal. This session is where you say which products you want covered first.

What if we cannot attend on the date?

Register anyway. The replay and the slides go to everyone who signs up. The live session runs Wednesday, September 16, 2026 at 11:00 AM ET, hosted by Jason Sinchak, and lasts 45 minutes plus Q&A. Registration is on this page.

Exploitability management for medical devices. FDA §524B methodologyExploitability proven at runtime95% faster than legacy testing Book a Demo
Platform
OverviewAvoid FDA DeficienciesAvoid Consulting FeesDigital Twin TraceabilityAI MedDevice PentestingExploitability VerificationVulnerability ChainingRemediation OptimizationRemote TestLink™Incident ResponseAutomated VEX & MetricsCVSSv4 Migration
Solutions
EnterpriseStartups / SMBs Postmarket SurveillanceIncident ResponseSecurity EngineeringRegulatory AffairsFDA §524BEU MDR/CRAEU REDNIS2IMDRF N60 / N73Japan MHLW
Why ELTON
One Solution Subscription TestingAI-NativeFDA ComplianceVerified ExploitabilityELTON vs. Legacy TestingThreat-Led AI PentestingMDDT MethodologyCredentialsDevice ModalitiesPricing
Resources
FDA Deficiency ListFDA Testing RequirementsFDA Cyber SOPs & TemplatesRemediation LibraryRegulatory GuidesWebinarsAI NewsletterThe End of Legacy TestingThe AI Vulnerability ExplosionSecurity AdvisoriesWhitepapersIntelligence & Blog
Company
AboutLeadershipCareersPartnershipsContact Meet ELTON